Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic

View source ↗

Summary

EU regulators indicate continued use of ACE inhibitors and ARB medicines is supported by latest data during the COVID-19 pandemic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Failure
• Hypertension
• Kidney Disease